Close
Close
Treatment Database
human monoclonal IgG2 antibody against tissue factor pathway inhibitor (TFPI)
Trade Name not avaiable
Orphan Indication Hemophilia A
USA Market Approval
USA Designation Date 25-03-2019
Sponsor Bayer HealthCare LLC
100 Bayer Boulevard, P.O. Box 915
Hanover, New Jersey, 07981
More about Hemophilia A
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
410 views
by Abidemi Uruejoma
638 views
by Abidemi Uruejoma
11,149 views